Project Number 5R01AG062359-03 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomics Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 6. Autophagy, Endocytosis and Membrane Trafficking c. Endosomal/Lysosomal Dysfunction Researcher and Organization Principal Investigator KAMPMANN, MARTIN Principal Investigator First Name MARTIN Principal Investigator Last Name KAMPMANN Awardee Organization University of California San Francisco Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-596: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) FY Overall Cost $646,006 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MILLER, MARILYN
